Shanghai Conant Optical Co., Ltd. (HKG:2276)

Market Cap	19.34B -7.6%
Revenue (ttm)	2.62B +4.6%
Net Income	676.56M +19.0%
EPS	1.43 +11.0%
Shares Out	484.09M
PE Ratio	27.90
Forward PE	24.50
Dividend	0.41 (1.00%)
Ex-Dividend Date	Jun 15, 2026

Volume	1,416,545
Open	39.48
Previous Close	39.48
Day's Range	38.16 - 39.96
52-Week Range	27.26 - 66.50
Beta	0.31
Analysts	Strong Buy
Price Target	63.54 (+58.98%)
Earnings Date	Aug 17, 2026

About Shanghai Conant Optical

Shanghai Conant Optical Co., Ltd. manufactures and sells resin spectacle lenses in Mainland China, the Americas, Asia, Europe, Oceania, and Africa. The company offers personalized, customized, and standardized lenses, such as UV++ series, 1.74 series, single vison, student, progressive, hi-vex, business, specialty, and anti-fog lenses, as well as UV shield and gaming glasses. It also provides after-sales support services. The company serves spectacle lens brand owners and international ophthalmic optic companies. Shanghai Conant Optical Co., Lt...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1996
• Employees: 2,890
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2276

Financial Performance

In 2025, Shanghai Conant Optical's revenue was 2.19 billion, an increase of 6.08% compared to the previous year's 2.06 billion. Earnings were 557.72 million, an increase of 30.22%.

Financial numbers in CNY

Analyst Summary

According to 9 analysts, the average rating for 2276 stock is "Strong Buy." The 12-month stock price target is $63.54, which is an increase of 58.98% from the latest price.

Price Target

$63.54

(58.98% upside)

Analyst Consensus: Strong Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 21, 2026

Data Sources Report a data error